SCHEMBL25293136

SCHEMBL25293136

Cn1nccc1-c1nc2cc(Br)cnc2[nH]1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
COMT P21964 1/20 0.36
ABL1 P00519 5/20 0.35
RET P07949 5/20 0.35
KDR P35968 4/20 0.35
CDK7 P50613 4/20 0.35
CDK5 Q00535 4/20 0.35
PRKAA1 Q13131 4/20 0.35
AURKB Q96GD4 4/20 0.35
CLK4 Q9HAZ1 4/20 0.35
BRD4 O60885 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
AURKA O14965 4/20 0.34
JAK2 O60674 3/20 0.34
GSK3B P49841 3/20 0.34
PTK2 Q05397 3/20 0.34
ROCK1 Q13464 3/20 0.34
LRRK2 Q5S007 3/20 0.34
FLT3 P36888 2/20 0.34
LIMK1 P53667 1/20 0.34
PDPK1 O15530 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25781990 0.77 COMT (0.39) COMTBRD4SMN1; SMN2ROCK1PIK3CD
SCHEMBL25403950 0.76 CCNE1 (0.41) COMTABL1BRD4AURKALATS1
SCHEMBL12521256 0.75 PTGES (0.35) ABL1RETKDRCDK7CDK5
SCHEMBL4840365 0.71 SMN1; SMN2 (0.41) ABL1RETKDRCDK7CDK5
SCHEMBL4843914 0.71 KDR (0.57) ABL1RETKDRCDK7CDK5
SCHEMBL2984405 0.71 ABL1 (0.41) ABL1RETKDRCDK7CDK5
SCHEMBL25781891 0.71 COMT (0.43) COMTABL1RETKDRCDK7
SCHEMBL31588150 0.71 SMN1; SMN2 (0.53) ABL1RETKDRCDK7CDK5
SCHEMBL1192302 0.71 SMN1; SMN2 (0.53) ABL1RETKDRCDK7CDK5
SCHEMBL13607760 0.71 PTGES (0.51) KDRCDK5AURKBCLK4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023168686-A1 SUBSTITUTED CYCLOPENTANES AS CDK2 INHIBITORS QILU REGOR THERAPEUTICS INC. (CN) 2023-09-14 WO disclosed
WO-2023168686-A1 SUBSTITUTED CYCLOPENTANES AS CDK2 INHIBITORS QILU REGOR THERAPEUTICS INC. (CN) 2023-09-14 WO disclosed
WO-2023116884-A1 CDK2 INHIBITORS AND USE THEREOF QILU REGOR THERAPEUTICS INC. (CN) 2023-06-29 WO disclosed
WO-2023116884-A1 CDK2 INHIBITORS AND USE THEREOF QILU REGOR THERAPEUTICS INC. (CN) 2023-06-29 WO disclosed